Kavana S

Kavana Therapeutics is a biotechnology company dedicated to the discovery and development of therapies targeting cellular senescence. Founded by industry veterans including Sol Barer, the company focuses on identifying novel mechanisms to eliminate or modulate senescent cells, which are implicated in aging and various chronic diseases such as fibrosis and cancer. Kavana utilizes a proprietary platform to develop a pipeline of senolytic and senomorphic agents aimed at extending human healthspan and treating unmet medical needs in age-related pathology. The company operates primarily in stealth mode, focusing on early-stage research and development of its therapeutic candidates.